StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.84−0.03 (-1.05%)

Close on Nov 17, 2026Market cap $560.13MP/E –Yield –

Wave Life Sciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Wave Life Sciences's price to sales ratio was 10.1× on Nov 11, 2026, against 6.7× a year earlier. Over the last 5 years it ranged from 2.0× to 145.6×, with a median of 15.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.1×−5.1
2024Oct 31, 202415.2×+9.3
2023Dec 29, 20235.8×−139.8
2022Dec 30, 2022145.6×+130.7
2021Apr 30, 202114.9×−14.5
2020Dec 31, 202029.4×+13.5
2019Dec 31, 201916.0×−88.1
2018Dec 31, 2018104.0×−176.8
2017Dec 29, 2017280.8×–

More Wave Life Sciences figures

See a number that looks wrong?